Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste 2 receptor member 63, pseudogene (TAS2R63P), also referred to as PS6, T2R63, taste receptor, type 2, member 63, pseudogene, describes a human pseudogene related to the bitter taste receptor family[3]. This gene is designated as a pseudogene, meaning it is a non-functional copy resulting from the loss of function during evolution, and is not considered to encode a functional receptor protein[3]. Taste receptor type 2 member 63, pseudogene, is a non-functional genomic sequence related to the human bitter taste receptor family (TAS2Rs). TAS2Rs are members of the G protein-coupled receptor family and mediate signal transduction for the perception of bitter compounds, playing a role in dietary choices and avoidance of toxins[1]. The TAS2R gene family includes 25 functional loci and at least 8–11 pseudogenes in humans, with pseudogenes such as TAS2R63P representing evolutionary loss of taste receptor function[3]. While functional TAS2R receptors participate in taste signal pathways by activating G proteins such as α-gustducin, pseudogenes like TAS2R63P have lost coding ability and do not produce active proteins or fulfill biological roles related to taste perception[3][1][2]. In summary: TAS2R63P is a pseudogene and not a therapeutic target, but can be referenced as a genomic remnant associated with the bitter taste receptor family. Its functional relatives play significant roles in taste perception, but this particular sequence is not a target for therapeutic intervention, drug interaction, or disease association[3][1].
Not applicable. No mechanism of action for a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 2 member 63, pseudogene (TAS2R63P).